XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jul. 31, 2021
Aug. 01, 2020
Jul. 31, 2021
Aug. 01, 2020
Income Statement [Abstract]        
Net sales $ 113,442,000 $ 124,515,000 $ 226,644,000 $ 220,349,000
Cost of sales 65,456,000 78,223,000 132,651,000 138,500,000
Gross profit 47,986,000 46,292,000 93,993,000 81,849,000
Operating expense:        
Distribution and selling 35,357,000 31,875,000 69,605,000 65,610,000
General and administrative 7,387,000 5,104,000 13,822,000 10,471,000
Depreciation and amortization 7,611,000 6,842,000 14,986,000 8,723,000
Restructuring costs       209,000
Total operating expense 50,355,000 43,821,000 98,413,000 85,013,000
Operating income (loss) (2,370,000) 2,471,000 (4,420,000) (3,164,000)
Other income (expense):        
Interest income 39,000   39,000 1,000
Interest expense (1,381,000) (1,402,000) (2,694,000) (2,581,000)
Loss on debt extinguishment (654,000)   (654,000)  
Total other expense, net (1,997,000) (1,402,000) (3,309,000) (2,580,000)
Income (loss) before income taxes (4,366,000) 1,069,000 (7,729,000) (5,744,000)
Income tax provision (15,000) (15,000) (30,000) (30,000)
Net income (loss) (4,381,000) 1,054,000 (7,759,000) (5,774,000)
Less: Net loss attributable to non-controlling interest (132,000)   (282,000)  
Net income (loss) attributable to shareholders $ (4,249,000) $ 1,054,000 $ (7,476,000) $ (5,774,000)
Net income (loss) per common share $ (0.23) $ 0.11 $ (0.45) $ (0.65)
Net income (loss) per common share - assuming dilution $ (0.23) $ 0.11 $ (0.45) $ (0.65)
Weighted average number of common shares outstanding:        
Basic 19,101,652 9,532,369 17,314,317 8,911,580
Diluted 19,101,652 9,896,729 17,314,317 8,911,580